Sandoz Canada Inc. launches PrTOBRAMYCIN INHALATION SOLUTION, a generic version of PrTOBI indicated for pulmonary infections in ...
BOUCHERVILLE, QC, March 31, 2016 (GLOBE NEWSWIRE) -- Sandoz Canada Inc. announced the launch of PrTOBRAMYCIN INHALATION SOLUTION, an authorized generic version of PrTOBI*, currently marketed by Novartis Pharmaceuticals Canada Inc. PrTOBRAMYCIN INHALATION …